Redefining Skin Biopsy

An innovative elliptical punch biopsy device that delivers superior cosmetic outcomes without compromising clinical efficiency

Learn More See It in Action Clinical Feedback Partnership Opportunities

The Problem

⚠️

Suboptimal Cosmesis

Conventional circular punch biopsies often leave puckered, widened, and cosmetically unfavorable scars

⏱️

Time Constraints

Traditional fusiform excisions yield better scars but are too time-consuming for high-volume clinical settings

📊

Limited Options

Clinicians must choose between speed and cosmetic outcome, with no optimal middle ground

Our Solution

Elliptical Punch Biopsy Device

The Revedeon elliptical punch biopsy device bridges the gap between speed and cosmetic outcome. Our patented technology produces an elliptical, fusiform-like defect without the extra time and complexity of traditional elliptical excisions.

✓

Superior Cosmesis

Creates linear wounds that align with relaxed skin tension lines

✓

Maintained Efficiency

Fast procedure time comparable to circular punches

✓

Adjustable Depth

Simple depth control without complex mechanisms

✓

Easy Adoption

Intuitive design fits seamlessly into existing workflows

✓

Cost-Effective

Low anticipated manufacturing cost

Device in Action

Watch the elliptical punch biopsy device compared to traditional circular punches

Technology & Innovation

Patented Design

The device incorporates a fusiform blade that creates an elliptical wound while maintaining the simplicity and speed of a traditional punch biopsy. This patented approach addresses a fundamental limitation in current dermatologic practice.

Clinical Advantages

By producing wounds that better align with relaxed skin tension lines, the device reduces puckering and improves healing outcomes. The result is a more cosmetically favorable linear scar that benefits both patients and practitioners.

Workflow Integration

Designed for seamless integration into high-volume clinical settings, the device maintains procedural efficiency while delivering superior cosmetic results. The adjustable depth control adds precision without adding complexity.

Comparative Advantages

vs. Circular Punches

  • Better cosmetic outcomes
  • Reduced scarring and puckering
  • Similar procedural speed
  • Comparable cost profile

vs. Fusiform Excisions

  • Significantly faster procedure
  • Simpler technique
  • Similar cosmetic results
  • Better workflow efficiency

vs. Complex Systems

  • Lower manufacturing cost
  • Easier adoption curve
  • No complex mechanisms
  • Proven design principles

Market Opportunity

Addressing a Clear Clinical Need

The elliptical skin biopsy device was developed through collaboration with fellowship-trained Mohs micrographic surgeons and biomedical engineers, translating firsthand clinical insights into an innovative solution for a persistent procedural challenge.

Target Markets

Dermatology Practices

High-volume dermatologists performing routine diagnostic biopsies and skin cancer evaluations

Plastic Surgery

Cosmetic and reconstructive surgeons prioritizing aesthetic outcomes in facial and visible areas

Primary Care

Family physicians and internal medicine practitioners performing outpatient skin procedures

Advanced Practice

Physician assistants and nurse practitioners conducting skin biopsies in clinic settings

Market Drivers

01

Growing Skin Cancer Incidence

Rising global rates of skin cancer drive increased diagnostic biopsy volumes across all practice settings

02

Cosmetic Expectations

Patient demand for optimal cosmetic outcomes continues to grow, particularly in aesthetic-conscious markets

03

Reimbursement Alignment

Compatible with existing reimbursement frameworks for small excisions, facilitating adoption

04

Practice Differentiation

Enables clinicians to differentiate their practice through superior patient outcomes and satisfaction

Strategic Development Goals

Revedeon seeks strategic partnerships to advance this technology through commercialization. Key near-term milestones include:

1

Design for Manufacturing

Refine design specifications and optimize for large-scale production

2

Preclinical Testing

Complete usability and user-experience evaluations with target clinicians

3

Regulatory Pathway

Confirm regulatory strategy and prepare initial submissions

4

Clinical Adoption

Establish early clinical use and collect post-market data on outcomes and satisfaction

Patent Information

US Patent No. 11,805,997 B2

Title: Skin Biopsy Device

Assignee: Revedeon, LLC

Date of Patent: November 7, 2023

The patent covers devices and methods for performing skin biopsies with consistent depth and shape. The device provides for reducing or eliminating operator error and inter-operator variability by generating the same forces across multiple uses, while also incorporating a fusiform blade to eliminate puckering of wound closures.

About the Founder

Alex Reid, MD

Alex Reid, MD

Fellowship-Trained Mohs Micrographic Surgeon

Dr. Reid brings extensive clinical experience in cutaneous oncology and procedural dermatology to the development of innovative surgical tools that improve patient outcomes.

Education & Training

  • Medical School: University of Michigan Medical School
  • Dermatology Residency: University of Iowa
  • Mohs Fellowship: Geisinger Medical Center

Vision

Through years of high-volume clinical practice performing skin cancer surgeries and diagnostic biopsies, the founder identified a persistent gap in available tools: conventional circular punch biopsies routinely produce suboptimal cosmetic outcomes, yet time constraints make traditional fusiform excisions impractical for most settings.

This device represents a direct translation of clinical insights into a practical solution—delivering improved cosmetic outcomes without compromising the efficiency that busy practices require. The goal is to elevate the standard of care in dermatologic procedures, benefiting both clinicians and patients.

Get in Touch

Partnership Opportunities

Revedeon is seeking strategic partners and collaborators to advance the elliptical punch biopsy device through commercialization. We welcome inquiries from:

  • Medical device manufacturers
  • Distribution partners
  • Clinical research organizations
  • Industry investors
Submit Partnership Inquiry

Company: Revedeon, LLC

Location: Waterloo, IA